Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium and thiamine for Wernicke-Korsakoff syndrome prevention
NCT03466528Phase 3Completed
- Sponsor
- Glasgow Royal Infirmary
- Start
- Dec 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate in Wernicke encephalopathy (WE), thiamine deficiency, magnesium deficiency, sponsored by Glasgow Royal Infirmary. Started Dec 2016; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
Wernicke encephalopathy (WE)thiamine deficiencymagnesium deficiency
Beyond the preview
Go deeper on NCT03466528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03466528.